Production (Stage)
Structure Therapeutics Inc.
GPCR
$24.55
-$0.10-0.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 836.88M | 883.52M | 915.29M | 927.12M | 436.45M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 12.74M | 7.69M | 8.37M | 10.50M | 12.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 849.62M | 891.21M | 923.65M | 937.62M | 449.36M |
|
|
|||||
| Total Current Assets | 849.62M | 891.21M | 923.65M | 937.62M | 449.36M |
| Net Property, Plant & Equipment | 10.83M | 7.01M | 7.74M | 7.58M | 7.82M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.10M | 5.11M | 1.82M | 1.83M | 47.00K |
| Total Assets | 866.55M | 903.33M | 933.22M | 947.03M | 457.23M |
|
|
|||||
| Total Accounts Payable | 8.71M | 8.02M | 8.45M | 2.21M | 6.54M |
| Total Accrued Expenses | 25.31M | 26.30M | 23.14M | 18.78M | 15.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.47M | 1.70M | 1.71M | 1.63M | 1.60M |
| Total Finance Division Other Current Liabilities | -- | -- | 139.00K | 41.00K | 297.00K |
| Total Other Current Liabilities | -- | -- | 139.00K | 41.00K | 297.00K |
| Total Current Liabilities | 36.49M | 36.02M | 33.43M | 22.66M | 23.59M |
|
|
|||||
| Total Current Liabilities | 36.49M | 36.02M | 33.43M | 22.66M | 23.59M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.12M | 2.16M | 2.67M | 3.05M | 3.53M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 308.00K | 302.00K | 309.00K | 293.00K | 296.00K |
| Total Liabilities | 41.91M | 38.49M | 36.42M | 26.00M | 27.41M |
|
|
|||||
| Common Stock & APIC | 1.20B | 1.19B | 1.19B | 1.18B | 662.52M |
| Retained Earnings | -375.93M | -329.10M | -292.62M | -258.64M | -232.61M |
| Treasury Stock & Other | 815.00K | 914.00K | 2.84M | -487.00K | -90.00K |
| Total Common Equity | 824.64M | 864.84M | 896.80M | 921.03M | 429.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 824.64M | 864.84M | 896.80M | 921.03M | 429.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 824.64M | 864.84M | 896.80M | 921.03M | 429.82M |
|
|
|||||